US Patent Issued to CREATE Medicines on Oct. 20 for "Methods and compositions for genomic integration" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,198, issued on Oct. 20, was assigned to CREATE Medicines Inc. (Cambridge, Mass.).

"Methods and compositions for genomic integration" was invented by Daniel Getts (Medfield, Mass.), Yuxiao Wang (Belmont, Mass.) and Namita Bisaria (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed."

The patent was filed on March 4, 2022, under Application No. 17/687,395.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITO...